Virtual LV Lead Navigation in Patients With Ischemic Cardiomyopathy

Sponsor
University of Pittsburgh (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01825239
Collaborator
Medtronic (Industry)
0
1
1
6
0

Study Details

Study Description

Brief Summary

Presently, the left ventricular lead is placed in a similar position for all patients. It is not known whether placing this lead in different positions in the heart will make the heart pump better. In this study, the investigator will collect measurements of the heart's electrical activity during an Electrophysiology Study (EP study or EPS). The hope is that these measurements will provide the know how to develop an individualized left ventricular lead placement "prescription" for patients referred for left ventricular lead pacing.

Condition or Disease Intervention/Treatment Phase
  • Other: Collection of measurements during LV pacing during electrophysiology study
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Virtual Left Ventricular Lead Navigation in Patients With Ischemic Cardiomyopathy
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Oct 1, 2014
Actual Study Completion Date :
Oct 1, 2014

Arms and Interventions

Arm Intervention/Treatment
Other: Electrophysiology Study

This is a single arm study, all study participants will be referred for an Electrophysiology Study

Other: Collection of measurements during LV pacing during electrophysiology study
During the electrophysiology study, measurements will be obtained while pacing from different left ventricular regions in context to scar as determined by SPECT-CT testing.

Outcome Measures

Primary Outcome Measures

  1. dP/dt measurements observed during pacing from different left ventricular regions [Measurements will be observed at the time of the electrophysiology study (EPS) at enrollment.]

    During the electrophysiology study, the dP/dt measurements will be observed during pacing from different left ventricular regions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ischemic cardiomyopathy

  • Intrinsic QRS duration >120 milliseconds

  • LV ejection fraction <40%

Exclusion Criteria:
  • Persistent atrial tachyarrhythmia

  • Active cardiac ischemia

  • Cerebrovascular accident within 6 months

  • Surgical or percutaneous cardiac revascularization procedure within 3 months

  • Under 18 years of age

  • Pregnant

  • Participating in a clinical study that would preclude enrollment

  • Unable to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 UPMC Presbyterian Hospital Pittsburgh Pennsylvania United States 15213

Sponsors and Collaborators

  • University of Pittsburgh
  • Medtronic

Investigators

  • Principal Investigator: David S. Schwartzman, MD, University of Pittsburgh

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
David Schwartzman, Professor of Medicine, Cardiac Electrophysiology, University of Pittsburgh, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01825239
Other Study ID Numbers:
  • PRO12070339
First Posted:
Apr 5, 2013
Last Update Posted:
Aug 7, 2015
Last Verified:
Aug 1, 2015
Keywords provided by David Schwartzman, Professor of Medicine, Cardiac Electrophysiology, University of Pittsburgh, University of Pittsburgh
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 7, 2015